State Of Alaska, Department Of Revenue Catalyst Pharmaceuticals, Inc. Transaction History
State Of Alaska, Department Of Revenue
- $8.95 Billion
- Q4 2024
A detailed history of State Of Alaska, Department Of Revenue transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 63,719 shares of CPRX stock, worth $1.33 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
63,719
Previous 63,666
0.08%
Holding current value
$1.33 Million
Previous $1.27 Million
5.06%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding CPRX
# of Institutions
346Shares Held
98.4MCall Options Held
13.4KPut Options Held
11.7K-
Black Rock Inc. New York, NY18.7MShares$389 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.43MShares$175 Million0.0% of portfolio
-
State Street Corp Boston, MA5.8MShares$121 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.13MShares$65.2 Million1.62% of portfolio
-
Dimensional Fund Advisors LP Austin, TX3.01MShares$62.7 Million0.02% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.14B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...